Cases & Deals

Rosetta Inpharmatics establishes patent portfolio for expression profiling, genomics, and bioinformatics

Clients Rosetta Inpharmatics, Inc.

On behalf of Rosetta Inpharmatics LLC (a wholly owned subsidiary of Merck & Co., Inc.), Jones Day prosecuted and assisted with the management of its patent portfolio relating to expression profiling, genomics, and bioinformatics.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.